Medical Imaging Reagents Market by Class (Contrast Reagents, Optical Reagents, and Nuclear Reagents), Technology (Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, and Quantum Dots) and Application (Diagnostics, Drug Discovery & Development, and Educational Research): Global Opportunity Analysis and Industry Forecast, 2019–2027
- ALL4162552
- 231 Pages
- October 2020
- Pharmaceuticals
Medical imaging reagents are chemicals used to visualize structures or organs, thus assisting physicians to better diagnose and detect diseases. Thus, these compounds are widely applicable in imaging and detection technologies used in the healthcare and medical industry and various life science-related fields such as biotechnology, medicine, and pharmaceutical research. The commonly used imaging technologies, such as computed tomography, X-ray, and magnetic resonance imaging, analyze anatomy & morphology of a human body; however, these techniques cannot detect any changes at the molecular level.
Rise in cases of chronic diseases such as cancer and cardiovascular diseases, surge in technological advancements, development in medical imaging reagents, and high unmet medical and diagnostic imaging procedure needs are the key factors that fuel growth of the global medical imaging reagents market. For instance, cardiovascular diseases are one of the leading causes of deaths across the globe. Moreover, aged patients are at highest risk of suffering from chronic diseases; thus, rapid increase in geriatric population is expected to further drive the demand for medical imaging reagents. In addition, growth in demand for medical imaging reagents, owing to rise in number of cancer patients who need superior diagnostic imaging techniques, such as photoacoustic imaging technique and imaging reagents, for improved diagnosis also contributes toward growth of the market. Moreover, rise in geriatric population, increase in expenditure on healthcare, and growth in demand for effective procedures and safe medication are expected to fuel the market growth.
In addition, another major factor that boosts medical imaging reagents market growth include rise in awareness related to early disease diagnosis. For instance, early diagnosis of chronic diseases increases chances of successful treatment. Therefore, healthcare providers continuously emphasize on early diagnosis of clinical disorders which include the use of medical imaging techniques that in turn involve the use of medical imaging reagents.
Conversely, untapped emerging markets in developing countries are expected to provide remunerative opportunities for the market players. For instance, healthcare systems in developing countries such as Brazil, India, and China have experienced significant increase in investments in healthcare and infrastructure which leads to surge in demand for genetic testing in the region. However, lack of imaging reagent suppliers and strict government regulations are expected to hinder growth of the market.
The global medical imaging reagents market is segmented on the basis of class, technology, application, and region. By class, it is divided into contrast reagents, optical reagents, and nuclear reagents. The technology segment includes nanoparticles, fluorescent dyes & probes, radiopharmaceuticals, fluorescent proteins, and quantum dots. By application, it is categorized into diagnostics, drug discovery & development, and educational research. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Taiwan and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The major players in the medical imaging reagents market are Bayer AG, Bracco SpA, Cardinal Health, Eli Lilly and Company, General Electric Company (GE Healthcare), Lantheus Holdings, Inc., LI-COR Biosciences Inc., Merck KGaA (Sigma-Aldrich), PerkinElmer, Inc., and Thermo Fisher Scientific Inc.
KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global medical imaging reagents market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
• By Class
o Contrast Reagents
o Optical Reagents
o Nuclear Reagents
• By Technology
o Nanoparticles
o Fluorescent Dyes & Probes
o Radiopharmaceuticals
o Fluorescent Proteins
o Quantum Dots
• By Application
o Diagnostics
o Drug Discovery & Development
o Educational Research
• By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Taiwan
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
• List of key players profiled in the report:
• Bayer AG,
• Bracco SpA
• Cardinal Health
• Eli Lilly and Company
• General Electric Company (GE Healthcare)
• Lantheus Holdings, Inc.
• LI-COR Biosciences Inc.
• Merck KGaA (Sigma-Aldrich)
• PerkinElmer, Inc.
• Thermo Fisher Scientific Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• CMC CONTRAST AB
• Koninklijke Philips N.V.
• Shimadzu Corporation
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of chronic diseases
3.5.1.2.Rise in awareness for early disease diagnosis
3.5.1.3.Surge in demand for diagnostic imaging procedures
3.5.2.Restraints
3.5.2.1.Shortage of supplies of imaging reagents
3.5.2.2.Lack of access in underdeveloped countries
3.5.3.Opportunities
3.5.3.1.Growth opportunities in emerging markets
3.5.4.Impact analysis
3.6.Covid-19 Impact analysis on medical imaging reagents market
CHAPTER 4:MEDICAL IMAGING REAGENTS MARKET, BY CLASS
4.1.Overview
4.1.1.Market size and forecast
4.2.Contrast reagents
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Optical reagents
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Nuclear reagents
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY
5.1.Overview
5.1.1.Market size and forecast
5.2.Nanoparticles
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Fluorescent dyes & probes
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
5.4.Radiopharmaceuticals
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country
5.5.Fluorescent proteins
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country
5.6.Quantum dots
5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region
5.6.3.Market analysis, by country
CHAPTER 6:MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Diagnostics
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Drug discovery & development
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
6.4.Educational research
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country
CHAPTER 7:MEDICAL IMAGING REAGENTS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. medical imaging reagents market, by class
7.2.2.1.2.U.S. medical imaging reagents market, by technology
7.2.2.1.3.U.S. medical imaging reagents market, by application
7.2.2.2.Canada
7.2.2.2.1.Canada medical imaging reagents market, by class
7.2.2.2.2.Canada medical imaging reagents market, by technology
7.2.2.2.3.Canada medical imaging reagents market, by application
7.2.2.3.Mexico
7.2.2.3.1.Mexico medical imaging reagents market, by class
7.2.2.3.2.Mexico medical imaging reagents market, by technology
7.2.2.3.3.Mexico medical imaging reagents market, by application
7.2.3.North America market size and forecast, by class
7.2.4.North America market size and forecast, by technology
7.2.5.North America market size and forecast, by application
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany medical imaging reagents market, by class
7.3.2.1.2.Germany medical imaging reagents market, by technology
7.3.2.1.3.Germany medical imaging reagents market, by application
7.3.2.2.France
7.3.2.2.1.France medical imaging reagents market, by class
7.3.2.2.2.France medical imaging reagents market, by technology
7.3.2.2.3.France medical imaging reagents market, by application
7.3.2.3.UK
7.3.2.3.1.UK medical imaging reagents market, by class
7.3.2.3.2.UK medical imaging reagents market, by technology
7.3.2.3.3.UK medical imaging reagents market, by application
7.3.2.4.Italy
7.3.2.4.1.Italy medical imaging reagents market, by class
7.3.2.4.2.Italy medical imaging reagents market, by technology
7.3.2.4.3.Italy medical imaging reagents market, by application
7.3.2.5.Spain
7.3.2.5.1.Spain medical imaging reagents market, by class
7.3.2.5.2.Spain medical imaging reagents market, by technology
7.3.2.5.3.Spain medical imaging reagents market, by application
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe medical imaging reagents market, by class
7.3.2.6.2.Rest of Europe medical imaging reagents market, by technology
7.3.2.6.3.Rest of Europe medical imaging reagents market, by application
7.3.3.Europe market size and forecast, by class
7.3.4.Europe market size and forecast, by technology
7.3.5.Europe market size and forecast, by application
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan medical imaging reagents market, by class
7.4.2.1.2.Japan medical imaging reagents market, by technology
7.4.2.1.3.Japan medical imaging reagents market, by application
7.4.2.2.China
7.4.2.2.1.China medical imaging reagents market, by class
7.4.2.2.2.China medical imaging reagents market, by technology
7.4.2.2.3.China medical imaging reagents market, by application
7.4.2.3.Australia
7.4.2.3.1.Australia medical imaging reagents market, by class
7.4.2.3.2.Australia medical imaging reagents market, by technology
7.4.2.3.3.Australia medical imaging reagents market, by application
7.4.2.4.India
7.4.2.4.1.India medical imaging reagents market, by class
7.4.2.4.2.India medical imaging reagents market, by technology
7.4.2.4.3.India medical imaging reagents market, by application
7.4.2.5.South Korea
7.4.2.5.1.South Korea medical imaging reagents market, by class
7.4.2.5.2.South Korea medical imaging reagents market, by technology
7.4.2.5.3.South Korea medical imaging reagents market, by application
7.4.2.6.Taiwan
7.4.2.6.1.Taiwan medical imaging reagents market, by class
7.4.2.6.2.Taiwan medical imaging reagents market, by technology
7.4.2.6.3.Taiwan medical imaging reagents market, by application
7.4.2.7.Rest of Asia-Pacific
7.4.2.7.1.Rest of Asia-Pacific medical imaging reagents market, by class
7.4.2.7.2.Rest of Asia-Pacific medical imaging reagents market, by technology
7.4.2.7.3.Rest of Asia-Pacific medical imaging reagents market, by application
7.4.3.Asia-Pacific market size and forecast, by class
7.4.4.Asia-Pacific market size and forecast, by technology
7.4.5.Asia-Pacific market size and forecast, by application
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil medical imaging reagents market, by class
7.5.2.1.2.Brazil medical imaging reagents market, by technology
7.5.2.1.3.Brazil medical imaging reagents market, by application
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia medical imaging reagents market, by class
7.5.2.2.2.Saudi Arabia medical imaging reagents market, by technology
7.5.2.2.3.Saudi Arabia medical imaging reagents market, by application
7.5.2.3.South Africa
7.5.2.3.1.South Africa medical imaging reagents market, by class
7.5.2.3.2.South Africa medical imaging reagents market, by technology
7.5.2.3.3.South Africa medical imaging reagents market, by application
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA medical imaging reagents market, by class
7.5.2.4.2.Rest of LAMEA medical imaging reagents market, by technology
7.5.2.4.3.Rest of LAMEA medical imaging reagents market, by application
7.5.3.LAMEA market size and forecast, by class
7.5.4.LAMEA market size and forecast, by technology
7.5.5.LAMEA market size and forecast, by application
CHAPTER 8:COMPANY PROFILES
8.1.BAYER AG
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.BRACCO SPA
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments
8.3.CARDINAL HEALTH
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.ELI LILLY AND COMPANY
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.LANTHEUS HOLDINGS, INC.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.LI-COR BIOSCIENCES INC.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.8.MERCK KGAA (SIGMA-ALDRICH)
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.PERKINELMER, INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.THERMO FISHER SCIENTIFIC, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
TABLE 01.MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027 ($MILLION)
TABLE 02.CONTRAST REAGENTS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.OPTICAL REAGENTS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.NUCLEAR REAGENTS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 05.MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 06.NANOPARTICLES MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 07.FLUORESCENT DYES AND PROBES MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 08.RADIOPHARMACEUTICALS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.FLUORESCENT PROTEINS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.QUANTUM DOTS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 11.MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 12.DIAGNOSTICS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.DRUG DISCOVERY & DEVELOPMENT MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 14.EDUCATIONAL RESEARCH MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 16.NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 17.U.S. MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 18.U.S. MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 19.U.S. MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 20.CANADA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 21.CANADA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 22.CANADA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 23.MEXICO MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 24.MEXICO MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 25.MEXICO MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 26.NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 27.NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 28.NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 29.EUROPE MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 30.GERMANY MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 31.GERMANY MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 32.GERMANY MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 33.FRANCE MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 34.FRANCE MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 35.FRANCE MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 36.UK MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 37.UK MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 38.UK MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 39.ITALY MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 40.ITALY MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 41.ITALY MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 42.SPAIN MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 43.SPAIN MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 44.SPAIN MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 45.REST OF EUROPE MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 46.REST OF EUROPE MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 47.REST OF EUROPE MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 48.EUROPE MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 49.EUROPE MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 50.EUROPE MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 51.ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 52.JAPAN MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 53.JAPAN MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 54.JAPAN MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 55.CHINA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 56.CHINA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 57.CHINA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 58.AUSTRALIA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 59.AUSTRALIA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 60.AUSTRALIA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 61.INDIA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 62.INDIA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 63.INDIA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 64.SOUTH KOREA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 65.SOUTH KOREA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 66.SOUTH KOREA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 67.TAIWAN MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 68.TAIWAN MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 69.TAIWAN MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 70.REST OF ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 71.REST OF ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 72.REST OF ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 73.ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 74.ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 75.ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 76.LAMEA MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 77.BRAZIL MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 78.BRAZIL MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 79.BRAZIL MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 80.SAUDI ARABIA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 81.SAUDI ARABIA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 82.SAUDI ARABIA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 83.SOUTH AFRICA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 84.SOUTH AFRICA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 85.SOUTH AFRICA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 86.REST OF LAMEA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 87.REST OF LAMEA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 88.REST OF LAMEA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 89.LAMEA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2019–2027
TABLE 90.LAMEA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2019–2027
TABLE 91.LAMEA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATION, 2019–2027
TABLE 92.BAYER: COMPANY SNAPSHOT
TABLE 93.BAYER: OPERATING SEGMENTS
TABLE 94.BAYER: PRODUCT PORTFOLIO
TABLE 95.BAYER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96.BRACCO: COMPANY SNAPSHOT
TABLE 97.BRACCO: OPERATING SEGMENT
TABLE 98.BRACCO: PRODUCT PORTFOLIO
TABLE 99.BRACCO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 101.CARDINAL HEALTH: OPERATING SEGMENT
TABLE 102.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 103.LILLY: COMPANY SNAPSHOT
TABLE 104.LILLY: PRODUCT PORTFOLIO
TABLE 105.LILLY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106.GE: COMPANY SNAPSHOT
TABLE 107.GE: OPERATING SEGMENT
TABLE 108.GE: PRODUCT PORTFOLIO
TABLE 109.GE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110.LANTHEUS: COMPANY SNAPSHOT
TABLE 111.LANTHEUS: PRODUCT PORTFOLIO
TABLE 112.LANTHEUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113.LI-COR: COMPANY SNAPSHOT
TABLE 114.LI-COR.: PRODUCT PORTFOLIO
TABLE 115.MERCK: COMPANY SNAPSHOT
TABLE 116.MERCK: OPERATING SEGMENTS
TABLE 117.MERCK: PRODUCT PORTFOLIO
TABLE 118.PERKINELMER: COMPANY SNAPSHOT
TABLE 119.PERKINELMER: OPERATING SEGMENT
TABLE 120.PERKINELMER: PRODUCT PORTFOLIO
TABLE 121.THERMO FISHER: COMPANY SNAPSHOT
TABLE 122.THERMO FISHER.: OPERATING SEGMENT
TABLE 123.THERMO FISHER.: PRODUCT PORTFOLIO
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
